131 results on '"Volloch"'
Search Results
2. Principles of Design of Clinical Trials for Prevention and Treatment of Alzheimer’s Disease and Aging-Associated Cognitive Decline in the ACH2.0 Perspective: Potential Outcomes, Challenges, and Solutions
3. The Amyloid Cascade Hypothesis 2.0 for Alzheimer’s Disease and Aging-Associated Cognitive Decline: From Molecular Basis to Effective Therapy
4. Effect of Lecanemab and Donanemab in Early Alzheimer’s Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective
5. Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane
6. Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane
7. The Amyloid Cascade Hypothesis 2.0: Generalization of the Concept
8. The Amyloid Cascade Hypothesis 2.0: On the Possibility of Once-in-a-Lifetime-Only Treatment for Prevention of Alzheimer’s Disease and for Its Potential Cure at Symptomatic Stages
9. Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane
10. Structural and functional characteristics of SARS-CoV-2 Omicron subvariant BA.2 spike
11. Structural and functional impact by SARS-CoV-2 Omicron spike mutations
12. Structural and functional impact by SARS-CoV-2 Omicron spike mutations
13. Structural and functional impact by SARS-CoV-2 Omicron spike mutations
14. Structural and functional impact by SARS-CoV-2 Omicron spike mutations
15. Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
16. Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
17. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
18. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
19. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
20. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
21. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
22. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
23. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
24. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
25. Structural impact on SARS-CoV-2 spike protein by D614G substitution
26. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
27. Structural impact on SARS-CoV-2 spike protein by D614G substitution
28. Structural impact on SARS-CoV-2 spike protein by D614G substitution
29. Structural impact on SARS-CoV-2 spike protein by D614G substitution
30. A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent
31. Mycobacterial and Plasmodium ovale‐associated destruction of the jaw bones
32. Structural impact on SARS-CoV-2 spike protein by D614G substitution
33. Distinct conformational states of SARS-CoV-2 spike protein
34. A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitro
35. Distinct conformational states of SARS-CoV-2 spike protein
36. Distinct conformational states of SARS-CoV-2 spike protein
37. Distinct conformational states of SARS-CoV-2 spike protein
38. Model of the HIV-1 gp41 membrane-proximal external region, transmembrane domain and cytoplasmic tail (LLP2)
39. Structure of the HIV-1 gp41 transmembrane domain and cytoplasmic tail (LLP2)
40. Structural basis of transmembrane coupling of the HIV-1 envelope glycoprotein
41. Alzheimer’s Disease is Driven by Beta-Amyloid Generated in the Amyloid Precursor Protein-Independent Pathway and Retained Intraneuronally: Research and Therapeutic Strategies in a New AD Paradigm
42. News from Mars: Two-Tier Paradox, Intracellular PCR, Chimeric Junction Shift, Dark Matter mRNA and Other Remarkable Features of Mammalian RNA-Dependent mRNA Amplification. Implications for Alzheimer’s Disease, RNA-Based Vaccines and mRNA Therapeutics
43. Mechanism for β-amyloid Overproduction in Alzheimer Disease
44. Protein-Encoding RNA-to-RNA Information Transfer in Mammalian Cells: Principles of RNA-Dependent mRNA Amplification
45. Protein-Encoding RNA-to-RNA Information Transfer in Mammalian Cells: Principles of RNA-Dependent mRNA Amplification
46. Protein-Encoding RNA to RNA Information Transfer in Mammalian Cells: RNA-dependent mRNA Amplification. Identification of Chimeric RNA Intermediates and Putative RNA End Products
47. AD “Statin”: Alzheimer’s Disorder is a “Fast” Disease Preventable by Therapeutic Intervention Initiated Even Late in Life and Reversible at the Early Stages
48. RNA-dependent Amplification of Mammalian mRNA Encoding Extracellullar Matrix Proteins: Identification of Chimeric RNA Intermediates for α1, β1, and γ1 Chains of Laminin
49. Alzheimer’s Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow
50. Protein-Encoding RNA-to-RNA Information Transfer in Mammalian Cells: Principles of RNA-Dependent mRNA Amplification
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.